Isolated epileptiform activity in children and adolescents: prevalence, relevance, and implications for treatment.
Ronald J SwatzynaMartijn ArnsJay D TarnowRobert P TurnerEmma BarrErin K MacInerneyAnne M HoffmanNash N BoutrosPublished in: European child & adolescent psychiatry (2020)
In the field of psychiatry diagnoses are primarily based on the report of symptoms from either the patient, parents, or both, and a psychiatrist's observations. A psychiatric diagnosis is currently the most widely used basis for medication selection and the brain is seldom investigated directly as a source of those symptoms. This study addresses the request from the National Institute of Mental Health (NIMH) Research Domain Criteria Project (RDoC) for scientific research into neurological abnormalities that can be linked to psychiatric symptoms for the purpose of predicting medication response. One such neurological abnormality that has been the focus of many studies over the last three decades is isolated epileptiform discharges (IEDs) in children and adolescents without seizures. We conducted a systematic review of the literature to determine prevalence rates of IEDs within diagnostic categories. We then compared the prevalence of IEDs in the selected literature to our IRB-approved data archive. Our study found a consistent high prevalence of IEDs specifically for ADHD (majority > 25%) and ASD (majority > 59%), and consistent low prevalence rates were found for Depression (3%). If children and adolescents have failed multiple medication attempts, and more than one-third of them have IEDs, then an EEG would be justified within the RDoC paradigm.
Keyphrases
- mental health
- risk factors
- autism spectrum disorder
- healthcare
- attention deficit hyperactivity disorder
- sleep quality
- systematic review
- adverse drug
- quality improvement
- depressive symptoms
- emergency department
- electronic health record
- big data
- machine learning
- physical activity
- intellectual disability
- atomic force microscopy
- high resolution
- drug administration
- smoking cessation